Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY [Phase 1, Phase 2]
This update covers an allogeneic bone marrow transplant using matched related or unrelated donors with FluBu conditioning and HiCy (high-dos…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)
This trial update reports serial analysis of donor chimerism in pediatric patients with refractory cytopenia of childhood who underwent redu…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Phase 1, Phase 2]
This completed Phase 1/2 clinical trial evaluated a conditioning regimen using Clofarabine and Busulfan for hematologic malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Stem Cell Transplantation for Patients With Cancers of the Blood [Phase 2]
Phase 2 trial update reporting results from stem cell transplantation for patients with blood cancers, including chronic myeloid leukemia, c…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants [Phase 2]
Phase 2 clinical trial update on methods to enhance safety and effectiveness of stem cell transplants.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases [Phase 1]
Phase 1 trial update on belinostat plus azacitidine in adults with advanced hematologic cancers. The study has completed enrollment and eval…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1]
This document reports the completion of a Phase 1 safety study of lintuzumab in patients with acute myeloid leukemia and myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps [Phase 1, Phase 2]
This Phase 1/2 study evaluated a two-step reduced-intensity conditioning regimen for bone marrow transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS [Phase 2]
Phase 2 open-label, multi-dose study of Panhematin in patients with myelodysplastic syndrome was terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia [Phase 2]
A Phase 2 trial evaluated antithymocyte globulin plus cyclosporine for myelodysplastic syndrome; the study is completed with results posted …
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome [Phase 2]
A Phase 2 trial comparing siltuximab plus best supportive care to placebo plus best supportive care in anemic patients with IPSS low- or int…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant [NA]
This clinical trial update reports the completion and results posting of a study evaluating pre-transplant treatment with 5-azacitidine in p…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers [Phase 2]
Phase 2 clinical trial update evaluating peptide vaccinations in patients with low-risk myeloid cancers, including myelodysplastic syndrome …
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy [Phase 2]
Phase 2 trial of WT1 peptide vaccine in high-risk hematologic malignancies (myelodysplastic syndrome, acute myeloid leukemia, and chronic my…
-
CLINICAL_TRIALS research · 2014-06-24Clinical Trial Update: Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS) [Phase 2]
An update on the Phase 2 study of AR-67 (DB-67) for Myelodysplastic Syndrome. The current trial status is UNKNOWN.
-
CLINICAL_TRIALS other · 2014-06-17Clinical Trial Update: Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients [Phase 2]
Phase 2 study of decitabine induction before allogeneic hematopoietic cell transplant in newly diagnosed myelodysplastic syndrome patients w…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients [Phase 1, Phase 2]
This is a Phase 1/2 dose-ranging study of lenalidomide in patients with non-5q deletion myelodysplastic syndrome (low- to intermediate-1 ris…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants [Phase 1]
Phase 1 trial evaluating total body irradiation with fludarabine followed by combined umbilical cord blood transplants has completed. The tr…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood [Phase 1, Phase 2]
Phase 1/2 trial evaluating Wilms' Tumor 1 protein vaccine for blood cancers has completed. Results were posted on 2014-05-08.
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors [Phase 1]
Phase 1 pilot study evaluating donor-derived natural killer cell infusions for refractory non-B lineage hematologic cancers and solid tumors…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome [Phase 2]
A Phase 2 trial (SIMIDIS) evaluating azacitidine in combination with beta-erythropoietin for myelodysplastic syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors [Phase 2]
Phase 2 trial results evaluate a bortezomib-based graft-versus-host disease prophylaxis strategy after allogeneic transplantation in patient…
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination [Phase 1, Phase 2]
Open-label Phase 1/2 clinical trial evaluating the safety and tolerability of donor-derived allogeneic B-cell concentrates to support immune…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Clofarabine in High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
A Phase 1/2 clinical trial of clofarabine for high-risk myelodysplastic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) [Phase 2]
Phase 2 trial update on thymoglobulin, sirolimus, and mycophenolate mofetil for preventing acute GVHD in hematologic malignancies; study ter…